SARS News and Research

RSS

Epidemiological characteristics and transmission dynamics of the Omicron outbreak under lockdown policies in Shanghai

Researchers assessed the epidemiological characteristics of the SARS-CoV-2 Omicron variant outbreak in Shanghai, China.

21 Jun 2022

The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

Researchers assessed the impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant.

21 Jun 2022

Only 20% of Americans have effective protection against Omicron infection

In a recent research paper published in the Clinical Infectious Diseases journal, scientists analyzed the population immunity against pre-Omicron and Omicron severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variants in U.S. counties and states up until December 1, 2021. Background

21 Jun 2022

Clonal diversity impacts longevity of T cell reaction specific to SARS-CoV-2 epitope

A recent article under review at the Nature Portfolio journal and currently available on the Research Square* preprint server analyzed the factors influencing the durability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitope-specific T cell reaction.

21 Jun 2022

After maternal COVID vaccination, infants have persistent anti-SARS-CoV-2 antibodies at 3 months

A recent article published in the journal Clinical Infectious Diseases assessed the kinetics of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies derived from mothers among infants in association with the timing of prenatal SARS-CoV-2 vaccination.

21 Jun 2022

An estimate of Omicron's fitness advantage

Researchers quantify the transmission advantage of the SARS-CoV-2 Omicron variant across forty countries.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

Each SARS-CoV-2 reinfection causes more severe disease

In a recent study under review at the Nature Portfolio journal and currently posted to the Research Square* preprint server, researchers at Washington University School of Medicine and VA Saint Louis Health Care System showed that acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection adds to the risks of all-cause mortality and hospitalization accrued during the first SARS-CoV-2 infection.

20 Jun 2022

Real-world study shows Paxlovid associated with lower hospitalization rates

In a recent study posted to the medRxiv* pre-print server, researchers investigated the effectiveness of nirmatrelvir plus ritonavir in preventing hospitalizations among individuals aged 50 or older and vaccinated for coronavirus disease 2019 (COVID-19).

20 Jun 2022

Illustrating a rapid response approach for monkeypox management

Researchers illustrated a rapid response strategy for managing monkeypox outbreaks.

20 Jun 2022

Implications of impaired type I interferon immunity and increasing COVID-19 severity

Researchers demonstrated that impaired type I interferon immunity is associated with increasing coronavirus disease 2019 severity.

20 Jun 2022

The feasibility of sperm cryopreservation for male COVID-19 patients

In an article recently published in Frontiers in Endocrinology, scientists deciphered the possibility of cryopreserving sperm of coronavirus disease 2019 (COVID-19) patients

20 Jun 2022

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

Researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among COVID-19 survivors hospitalized for acute infection and those having long COVID.

20 Jun 2022

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

In a recent study posted to the medRxiv* preprint server, researchers explored the association between circulating coronavirus disease 2019 (COVID-19) antigens and post-COVID-19 sequelae (long COVID).

20 Jun 2022

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs) by genetic mismatch/distance (GD) analysis.

20 Jun 2022

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

In a recent study posted to the bioRxiv* preprint server, researchers at Weill Cornell Medical College assessed the cleavability of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and related coronaviruses by several proteases of the host.

19 Jun 2022

How effective are mRNA COVID-19 vaccine boosters against Omicron?

In a recent study posted to the medRxiv* preprint server, researchers University of Washington, University of Michigan, Duke University, and Veterans Affairs Portland Healthcare System assessed the effectiveness of the coronavirus disease 2019 (COVID-19) booster vaccines.

19 Jun 2022

Long-COVID risk reduced with Omicron versus Delta

In a recent study published in The Lancet, researchers at King's College London and ZOE Limited assessed the risk of long coronavirus disease (COVID) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants in the United Kingdom (UK).

19 Jun 2022

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

When a person sneezes or coughs, they can potentially transmit droplets carrying viruses like SARS-CoV-2 to others in their vicinity.

17 Jun 2022

Neuropsychiatric symptoms among patients with long COVID

More than two years after the COVID-19 pandemic erupted, scientists have become increasingly aware of a group of patients -; so-called 'long haulers' -; who remain plagued by a combination of symptoms long after the infection passes.

17 Jun 2022

SARS News and Research

Epidemiological characteristics and transmission dynamics of the Omicron outbreak under lockdown policies in Shanghai

The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

Only 20% of Americans have effective protection against Omicron infection

Clonal diversity impacts longevity of T cell reaction specific to SARS-CoV-2 epitope

After maternal COVID vaccination, infants have persistent anti-SARS-CoV-2 antibodies at 3 months

An estimate of Omicron's fitness advantage

How specific comorbidities impact severity of COVID-19

Each SARS-CoV-2 reinfection causes more severe disease

Real-world study shows Paxlovid associated with lower hospitalization rates

Illustrating a rapid response approach for monkeypox management

Implications of impaired type I interferon immunity and increasing COVID-19 severity

The feasibility of sperm cryopreservation for male COVID-19 patients

Evaluating post-acute sequelae of COVID-19 using cardiopulmonary exercise testing

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

How effective are mRNA COVID-19 vaccine boosters against Omicron?

Long-COVID risk reduced with Omicron versus Delta

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

Neuropsychiatric symptoms among patients with long COVID

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News